Neuroglee Health

Neuroglee Health is a value-based dementia care management company whose mission is to improve access, experience, and costs for patients with cognitive impairment and their families. The company provides personalized clinical care, care coordination, and care partner support across all stages of cognitive impairment — from pre-diagnosis early signs to severe dementia — using a proprietary, clinically proven intervention developed in partnership with the Mayo Clinic. Neuroglee's care model promotes the highest level of sustained function and independence and is delivered virtually through its Neuroglee Connect platform. The company partners with ACOs, risk-bearing provider organizations, and health plans to deliver and coordinate value-based dementia care that improves outcomes, lowers costs, and enhances the patient and care partner experience through flexible payment arrangements. Founded in 2020 and headquartered in Boston, Massachusetts, with additional offices in Singapore and Bengaluru, Neuroglee raised a $10 million Series A in September 2021.